Pharma Journalist 8769 posts 0 comments

argenx SE, a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, announced that the U.S. Food and Drug Administration (FDA)…
Read More...

Biopharmaceutical company Cingulate Inc. has been awarded a $3 million grant from a private foundation to accelerate the development of its once-daily anxiety treatment, CTx-2103…
Read More...

Biocon Biologics Ltd (BBL), a subsidiary of Biocon Ltd, has received approval from the U.S. Food and Drug Administration (FDA) for its cancer treatment biosimilar, Jobevne…
Read More...

The U.S. Food and Drug Administration (FDA) has announced a significant shift in drug development, aiming to replace animal testing with more effective, human-relevant methods. This…
Read More...

Renovaro Biosciences Inc., a TechBio leader focused on next-generation diagnostics, drug discovery, and genetically enhanced cancer therapies, announced it closed its previously…
Read More...

Epsilogen announces that it has completed the acquisition of TigaTx, Inc., a biotechnology company developing engineered immunoglobulin A (IgA) antibodies, to create the world’s leading…
Read More...

ALX Oncology Holdings Inc., announced receipt of U.S. Food and Drug Administration (FDA) clearance for the Investigational New Drug (IND) application for ALX2004, the company’s…
Read More...

Avidity Biosciences, Inc. announced that the Japan Ministry of Health, Labour and Welfare (MHLW) has granted Orphan Drug designation (ODD) to delpacibart etedesiran (del-desiran) for…
Read More...

Engine Biosciences (Engine), a Singapore- and Silicon Valley-based biotechnology company pioneering precision medicine for cancer, announced a new partnership with the Experimental Drug…
Read More...

POXEL SA, a clinical stage biopharmaceutical company developing innovative treatments for chronic serious diseases with metabolic pathophysiology, including metabolic…
Read More...